OncoSec Medical Incorporated
ONCSQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.65M
Close$
Share Statistics
| Market cap | $1.65 Million |
|---|---|
| Enterprise Value | $1.43 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 549.36% |
|---|---|
| Return on Assets | -339.76% |
| Return on Invested Capital | -1990.76% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.04 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 2.42 |
| Debt to Equity | -0.63 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
October 23, 2026
EPS Estimate
$-6.75
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About OncoSec Medical Inc
40 employees
CEO: Daniel O'Connor OncoSec Medical Incorporated was an immuno-oncology firm focused on the advanced stages of drug development. Its primary mission involved devising, perfecting, and bringing to market DNA-based treatments administered directly into tumors...